https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-10-28 / Mol Ther Oncol 2024 Dec;32(4):200898
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-10-28 / Mol Ther Oncol 2024 Dec;32(4):2008982024-10-28 00:00:002024-10-28 00:00:00Newcastle disease virus harboring the PTEN gene inhibits pancreatic cancer growth by inhibiting PI3K/AKT/mTOR signaling and activating apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-07-01 / J Clin Oncol 2024 Sep;42(26):3083-3093
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-07-01 / J Clin Oncol 2024 Sep;42(26):3083-30932024-07-01 00:00:002024-07-01 00:00:00Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-05-28 / Ann Transl Med 2024 Aug;12(4):77
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-05-28 / Ann Transl Med 2024 Aug;12(4):772024-05-28 00:00:002025-02-25 11:37:38Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-14 / Cancer Immunol Immunother 2023 Feb;72(2):301-313
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-14 / Cancer Immunol Immunother 2023 Feb;72(2):301-3132022-07-14 00:00:002022-07-14 00:00:00Personalized tumor vaccine for pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-09 / Heliyon 2022 Jul;8(7):e09915
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-09 / Heliyon 2022 Jul;8(7):e099152022-07-09 00:00:002022-07-09 00:00:00Comparison between intratumoral and intravenously administered oncolytic virus therapy with Newcastle disease virus in a xenograft murine model for pancreatic adenocarcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-06-16 / BMJ Open 2022 Jun;12(6):e060431
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-06-16 / BMJ Open 2022 Jun;12(6):e0604312022-06-16 00:00:002022-06-16 00:00:00Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer: protocol for a phase I, open-label, single-arm, dose-escalation study (REACtiVe-2 trial)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-04-28 / Eur J Cancer 2022 Jul;169:20-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-04-28 / Eur J Cancer 2022 Jul;169:20-312022-04-28 00:00:002022-04-28 00:00:00Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-12-17 / Hum Vaccin Immunother 2021 Dec;17(12):5563-5572
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-12-17 / Hum Vaccin Immunother 2021 Dec;17(12):5563-55722021-12-17 00:00:002021-12-17 00:00:00Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-12-10 / Pathol Oncol Res 2021;27:1610048
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-12-10 / Pathol Oncol Res 2021;27:16100482021-12-10 00:00:002021-12-10 00:00:00Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-24 / World J Clin Oncol 2021 Nov;12(11):1064-1071
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-24 / World J Clin Oncol 2021 Nov;12(11):1064-10712021-11-24 00:00:002021-11-24 00:00:00Modulated electro-hyperthermia in stage III and IV pancreatic cancer: Results of an observational study on 158 patients
